Cargando…

18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells

BACKGROUND: At present, the treatment and prevention of Pasteurella multocida infections in pigs mainly rely on antibiotics and vaccines, but inflammatory injury cannot be eliminated. The compound 18β-glycyrrhetinic acid (GA), a pentacyclic triterpenoid extracted from Glycyrrhiza glabra L. root (liq...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qirong, Han, Wantong, Wen, Defeng, Guo, Pu, Liu, Yu, Wu, Zhongyuan, Fu, Shulin, Ye, Chun, Wang, Xu, Qiu, Yinsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317536/
https://www.ncbi.nlm.nih.gov/pubmed/37404255
http://dx.doi.org/10.2147/IDR.S413242
_version_ 1785067890313003008
author Lu, Qirong
Han, Wantong
Wen, Defeng
Guo, Pu
Liu, Yu
Wu, Zhongyuan
Fu, Shulin
Ye, Chun
Wang, Xu
Qiu, Yinsheng
author_facet Lu, Qirong
Han, Wantong
Wen, Defeng
Guo, Pu
Liu, Yu
Wu, Zhongyuan
Fu, Shulin
Ye, Chun
Wang, Xu
Qiu, Yinsheng
author_sort Lu, Qirong
collection PubMed
description BACKGROUND: At present, the treatment and prevention of Pasteurella multocida infections in pigs mainly rely on antibiotics and vaccines, but inflammatory injury cannot be eliminated. The compound 18β-glycyrrhetinic acid (GA), a pentacyclic triterpenoid extracted from Glycyrrhiza glabra L. root (liquorice) and with a chemical structure similar to that of steroidal hormones, has become a research focus because of its anti-inflammatory, antiulcer, antimicrobial, antioxidant, immunomodulatory, hepatoprotective and neuroprotective effects, but its potential for the treatment of vascular endothelial inflammatory injury by P. multocida infections has not been evaluated. This study aimed to investigate the effects and mechanisms of GA intervention in the treatment of vascular endothelial inflammatory injury by P. multocida infections. MATERIALS AND METHODS: Putative targets of GA intervention in the treatment of vascular endothelial inflammatory injury by P. multocida infections were identified using network pharmacological screening and molecular docking simulation. The cell viability of PIEC cells was investigated via the CCK-8 assay. The mechanism of GA intervention in the treatment of vascular endothelial inflammatory injury by P. multocida infections were investigated using cell transfection and western blot. RESULTS: Through network pharmacological screening and molecular docking simulation, this study found that PARP1 may be a core target for GA to exert anti-inflammatory effects. Mechanistically, GA alleviates P. multocida-induced vascular endothelial inflammation by PARP1-mediated NF-κB and HMGB1 signalling suppression. CONCLUSION: These findings, for the first time, demonstrate the potential therapeutic relationship among GA, PARP1 and inflammatory injury, providing a candidate drug, therapeutic targets and explanation for treating vascular endothelial inflammatory injury caused by P. multocida infection.
format Online
Article
Text
id pubmed-10317536
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103175362023-07-04 18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells Lu, Qirong Han, Wantong Wen, Defeng Guo, Pu Liu, Yu Wu, Zhongyuan Fu, Shulin Ye, Chun Wang, Xu Qiu, Yinsheng Infect Drug Resist Original Research BACKGROUND: At present, the treatment and prevention of Pasteurella multocida infections in pigs mainly rely on antibiotics and vaccines, but inflammatory injury cannot be eliminated. The compound 18β-glycyrrhetinic acid (GA), a pentacyclic triterpenoid extracted from Glycyrrhiza glabra L. root (liquorice) and with a chemical structure similar to that of steroidal hormones, has become a research focus because of its anti-inflammatory, antiulcer, antimicrobial, antioxidant, immunomodulatory, hepatoprotective and neuroprotective effects, but its potential for the treatment of vascular endothelial inflammatory injury by P. multocida infections has not been evaluated. This study aimed to investigate the effects and mechanisms of GA intervention in the treatment of vascular endothelial inflammatory injury by P. multocida infections. MATERIALS AND METHODS: Putative targets of GA intervention in the treatment of vascular endothelial inflammatory injury by P. multocida infections were identified using network pharmacological screening and molecular docking simulation. The cell viability of PIEC cells was investigated via the CCK-8 assay. The mechanism of GA intervention in the treatment of vascular endothelial inflammatory injury by P. multocida infections were investigated using cell transfection and western blot. RESULTS: Through network pharmacological screening and molecular docking simulation, this study found that PARP1 may be a core target for GA to exert anti-inflammatory effects. Mechanistically, GA alleviates P. multocida-induced vascular endothelial inflammation by PARP1-mediated NF-κB and HMGB1 signalling suppression. CONCLUSION: These findings, for the first time, demonstrate the potential therapeutic relationship among GA, PARP1 and inflammatory injury, providing a candidate drug, therapeutic targets and explanation for treating vascular endothelial inflammatory injury caused by P. multocida infection. Dove 2023-06-29 /pmc/articles/PMC10317536/ /pubmed/37404255 http://dx.doi.org/10.2147/IDR.S413242 Text en © 2023 Lu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lu, Qirong
Han, Wantong
Wen, Defeng
Guo, Pu
Liu, Yu
Wu, Zhongyuan
Fu, Shulin
Ye, Chun
Wang, Xu
Qiu, Yinsheng
18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells
title 18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells
title_full 18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells
title_fullStr 18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells
title_full_unstemmed 18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells
title_short 18β-Glycyrrhetinic Acid Alleviates P. multocida-Induced Vascular Endothelial Inflammation by PARP1-Mediated NF-κB and HMGB1 Signalling Suppression in PIEC Cells
title_sort 18β-glycyrrhetinic acid alleviates p. multocida-induced vascular endothelial inflammation by parp1-mediated nf-κb and hmgb1 signalling suppression in piec cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317536/
https://www.ncbi.nlm.nih.gov/pubmed/37404255
http://dx.doi.org/10.2147/IDR.S413242
work_keys_str_mv AT luqirong 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT hanwantong 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT wendefeng 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT guopu 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT liuyu 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT wuzhongyuan 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT fushulin 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT yechun 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT wangxu 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells
AT qiuyinsheng 18bglycyrrhetinicacidalleviatespmultocidainducedvascularendothelialinflammationbyparp1mediatednfkbandhmgb1signallingsuppressioninpieccells